Table 2. Relationship between clinicopathological characteristics and BRD4 expression in patients with gastric carcinoma.
| Characteristics | BRD4 expression | p value | |
|---|---|---|---|
| Low (%) | High (%) | ||
| Age (years) | |||
| < 60 | 21 (53.8) | 18 (46.2) | 1.000 |
| ≥ 60 | 29 (51.8) | 27 (48.2) | |
| Gender | |||
| Male | 38 (54.3) | 32 (45.7) | 0.645 |
| Female | 12 (48.0) | 13 (52.0) | |
| Drinking or smoking | |||
| No | 27 (58.7) | 19 (41.3) | 0.306 |
| Yes | 23 (46.9) | 26 (53.1) | |
| TNM stage | |||
| T1 | 17 (85.0) | 3 (15.0) | <0.001 |
| T2 | 15 (75.0) | 5 (25.0) | |
| T3 | 10 (47.6) | 11 (52.4) | |
| T4 | 8 (23.5) | 26 (76.5) | |
| Lymphatic permeation | |||
| Absent | 24 (70.6) | 10 (29.4) | 0.011 |
| Present | 26 (42.6) | 35 (57.4) | |
| Histologic type | |||
| Adenocarcinoma | 46 (53.5) | 40 (46.5) | 0.731 |
| Signet-ring cell carcinoma | 4 (44.4) | 5 (55.6) | |
| EGFR expression | |||
| Low | 37 (50.7) | 36 (49.3) | 0.804 |
| High | 11 (55.0) | 9 (45.0) | |
| Vital status (at the end of follow-up) | |||
| Alive | 35 (89.7) | 4 (10.3) | < 0.001 |
| Dead | 15 (26.8) | 41 (73.2) | |
Note: Bold values are significant at p < 0.05.